FDA Inspection 960944 — New York Blood Center, Inc.
The FDA completed an inspection of New York Blood Center, Inc. on Feb 26, 2016 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 26, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)